Retraction
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6
Paper Information
Record ID:
26494
Author(s):
Publication Date:
October 21, 2014
Retraction Date:
March 03, 2021
(4.7 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (23)
23
Total Citations4
Post-Retraction(17.4%)
18
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
1
After 2+ years
836
Days since retraction (latest)
Paper citing The Parkinson’s Disease Death Rate: Carbidopa and ...
Unknown Authors
Unknown Journal
Published: Unknown
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson’s disease
Thomas Müller, Peter Riederer
Journal of Neural Transmission
Published: Jun 2023
8 citations
8 citations
836 days after retraction
Velvet bean ( <scp> <i>Mucuna pruriens</i> </scp> ): A sustainable protein source for tomorrow
Chinju Baby, Sawinder Kaur, Jyoti Singh et al. (4 authors)
Legume Science
Open Access
Published: Dec 2022
6 citations
6 citations
666 days after retraction
Paper citing The Parkinson’s Disease Death Rate: Carbidopa and ...
Unknown Authors
Unknown Journal
Published: Feb 2022
360 days after retraction
GOCOVRI <sup>®</sup> (amantadine) extended-release Capsules in Parkinson’s Disease
Thomas Müller
Neurodegenerative Disease Management
Published: Dec 2021
3 citations
3 citations
289 days after retraction
Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
Thomas Müller
Journal of Experimental Pharmacology
Open Access
Published: Mar 2021
11 citations
11 citations
2 days before retraction
Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
Olakunle J. Onaolapo, Ademola O. Odeniyi, Adejoke Y. Onaolapo
CNS & Neurological Disorders - Drug Targets
Published: Feb 2021
13 citations
13 citations
12 days before retraction
Tryptophan Metabolism as a Pharmacological Target
Morgane Modoux, Nathalie Rolhion, Sridhar Mani et al. (4 authors)
Trends in Pharmacological Sciences
Open Access
Published: Nov 2020
231 citations
231 citations
96 days before retraction
Paper citing Parkinson’s Disease: Carbidopa, Nausea, and Dyskin...
Unknown Authors
Unknown Journal
Published: Sep 2020
183 days before retraction
Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues
Yukihiro Yoshida, Hidetsugu Fujigaki, Koichi Kato et al. (11 authors)
Scientific Reports
Open Access
Published: Jul 2019
24 citations
24 citations
597 days before retraction
Skeletal muscle PGC-1α1 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance
Leandro Z. Agudelo, Duarte M. S. Ferreira, Shamim Dadvar et al. (14 authors)
Nature Communications
Open Access
Published: Jun 2019
106 citations
106 citations
618 days before retraction
Long-term management of Parkinson’s disease using levodopa combinations
Thomas Müller, Jan-Dominique Möhr
Expert Opinion on Pharmacotherapy
Published: Jun 2018
21 citations
21 citations
994 days before retraction
Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters
Gayan Jayawickrama, Alireza Nematollahi, Guanchen Sun et al. (4 authors)
PLoS ONE
Open Access
Published: Apr 2018
13 citations
13 citations
1044 days before retraction
Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives
Gayan Jayawickrama, Alireza Nematollahi, Guanchen Sun et al. (5 authors)
Scientific Reports
Open Access
Published: Dec 2017
49 citations
49 citations
1181 days before retraction
Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
Eyad T. Marashly, Saeed Bohlega
Frontiers in Neurology
Open Access
Published: Jul 2017
110 citations
110 citations
1322 days before retraction
Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy
Carsten Buhmann, R. Hilker, Paul Lingor et al. (7 authors)
Journal of Neural Transmission
Published: Feb 2017
8 citations
8 citations
1470 days before retraction
Candidate novel long noncoding RNAs, MicroRNAs and putative drugs for Parkinson's disease using a robust and efficient genome-wide association study
Zahra Mortezaei, Hossein Lanjanian, Ali Masoudi‐Nejad
Genomics
Published: Feb 2017
25 citations
25 citations
1470 days before retraction
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease
Dominic J. Hare, Bárbara Rita Cardoso, Erika P. Raven et al. (7 authors)
npj Parkinson s Disease
Open Access
Published: Jan 2017
69 citations
69 citations
1518 days before retraction
Emerging approaches in Parkinson&rsquo;s disease &ndash; adjunctive role of safinamide
Thomas Müller
Therapeutics and Clinical Risk Management
Open Access
Published: Aug 2016
10 citations
10 citations
1675 days before retraction
Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders
Alireza Nematollahi, Guanchen Sun, Gayan Jayawickrama et al. (5 authors)
Molecules
Open Access
Published: Jun 2016
19 citations
19 citations
1708 days before retraction
Parkinson&rsquo;s disease managing reversible neurodegeneration
Marty Hinz, Alvin Stein, Ted Cole et al. (5 authors)
Neuropsychiatric Disease and Treatment
Open Access
Published: Apr 2016
3 citations
3 citations
1797 days before retraction
Do we need a new levodopa?
Thomas Müller
Neural Regeneration Research
Open Access
Published: Jan 2016
2 citations
2 citations
1888 days before retraction
Parkinson&#39;s disease: carbidopa, nausea, and dyskinesia
Marty Hinz, Alvin Stein, Ted Cole
Clinical Pharmacology Advances and Applications
Open Access
Published: Nov 2014
12 citations
12 citations
2314 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #23468
Apr 23, 2020Quick Stats
Total Citations:
23
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025